SECURITIES AND EXCHANGE COMMISSION

 

Washington, D.C. 20549

 

FORM 11-K

 

(Mark One)

 

ý ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED]

 

For the fiscal year ended December 31, 2004

 

OR

 

o TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934 [NO FEE REQUIRED]

 

For the transition period from                                             to                                            

 

Commission file number 1-9912

 

99.A.       Full title of the plan and the address of the plan, if different from that of the issuer named below:

 

NOVA Chemicals Inc. Capital Accumulation Plan

1550 Coraopolis Heights Road

Moon Township, Pennsylvania   15108

 

99.B.       Name of issuer of the securities held pursuant to the plan and the address of its principal executive office:

 

NOVA Chemicals Corporation

Post Office Box 2518, Station M

1000 Seventh Avenue SW

Calgary, Alberta   T2P 5C6

 

1.                                       The Audited Financial Statements, including the statement of net assets available for plan benefits and statement of changes in net assets available for plan benefits, attached hereto as Exhibit “A”.

 

2.             The Consent of Independent Accountants which is attached hereto as Exhibit “B”.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the trustee (or other persons who administer the employee benefit plan) have duly caused this annual report to be signed on its behalf by the undersigned hereto duly authorized.

 

 

NOVA Chemicals Inc. Capital Accumulation Plan

 

 

	/s/ BILL BRENGEL		/s/ LARRY A. MACDONALD
	Signature		Signature
	BILL BRENGEL		LARRY A. MACDONALD
	(Print Name)		(Print Name)
Date:	June 30, 2005

 

2